Immunotherapy Bridge 2016
Preliminary Program Royal Continental Hotel, Naples
November 30th, 2016
*to be confirmed
09.30 – 10.00 Registration
Session I - Immunotherapy Beyond Melanoma
Chairpersons: Alfredo Budillon, Graham Pawelec
10.00 - 10.20 What we learned from immunotherapy in melanoma, Paolo A. Ascierto 10.20 - 10.40 Checkpoint inhibitors anti PD1/PDL1 in metastatic NSCLC, Vera Hirsh 10.40 - 11.00 Title TBD, Charles Drake*
11.00 - 11.20 Title TBD, Joseph Kim 11.20 - 11.35 Break
11.35 - 12.35 Oral Communications 12.35 - 13.35 Sponsored Symposium 13.35 - 14.20 Lunch
Session II - Immunotherapy in Oncology: Data from clinical trials
Chairpersons: Rolf Kiessling, Sandro Pignata 14.20 – 15.20 Sponsored Symposium 15.20 - 15.40 Title TBD, Lisa Licitra 15.40 - 16.00 Title TBD, Antonello Pinto*
16.00 - 16.15 Break
16.15 - 16.35 Immunotherapy for Breast Cancer: Recent Clinical Trial Results, Rita Nanda 16.35 - 16.55 TBD
16.55 - 17.55 Oral Communications
17.55 - 18.10 Conclusions, Paolo A. Ascierto
Presidency Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Bernard A. Fox
Chief of the Laboratory of Molecular and Tumor Immunology, Oregon Health and Science University, Providence Cancer Center, Portland Medical Center, Oregon
Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar Scientific Board
Sanjiv Agarwala
Chief of Medical oncology and Hematology, St. Luke’s University Hospital and Temple University, Bethlehem, Pennsylvania
Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Gennaro Ciliberto
Scientific Director, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy Reinhard Dummer
Professor of Dermatology, University of Zurich Hospital, Department of Dermatology, Zurich Bernard A. Fox
Chief of the Laboratory of Molecular and Tumor Immunology, Oregon Health and Science University, Providence Cancer Center, Portland Medical Center, Oregon
Claus Garbe
University Professor of Dermatology, Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen, Germany
Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar Giuseppe Masucci
Professor, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden Nicola Mozzillo
Director of the Department of Surgical Oncology B, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Michael Postow
Memorial Sloan Kettering Cancer Center, New York
Igor Puzanov
Professor of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee
Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland
Ena Wang
Division Chief of Translational Medicine, Sidra Medical and Research Centre, Doha, Qatar
Tara Withington
Executive Director, Society for Immunotherapy of Cancer, Milwaukee Faculty
Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Julie Brahmer
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland Alfredo Budillon
National Cancer Institute “Fondazione G. Pascale” of Naples, Italy Charles G. Drake
Prostate Cancer Multi-Disciplinary Clinic, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Hans Hammers
UT Southwestern, Medical Center, Dallas, Texas Vera Hirsh
McGill University Health Centre Cedars Cancer Centre, Montreal, Quebec Rolf Kiessling
Karolinska Institutet, Stockholm, Sweden Joseph W. Kim
Yale School of Medicine, Yale Lisa Licitra
National Cancer Institute “Fondazione IRCCS”, Milan, Italy Rita Nanda
Section of Hematology - Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois
Graham Pawelec
Second Deperment of Internal Medicine, University of Tuebingen, Tuebingen, Germany Sandro Pignata
Istituto Nazionale Tumori “Fondazione G. Pascale”, Naples, Italy
Antonello Pinto
Istituto Nazionale Tumori “Fondazione G. Pascale”, Naples, Italy
